KRASG12C-targeted therapies like sotorasib and adagrasib have been approved, but resistance challenges persist, necessitating further research into RAS(ON) therapies. Revolution Medicines is ...
Researchers conducted a single-centre retrospective study to examine the efficacy and safety of 12 months of treatment with GLP-1 RAs in patients who had weight regain after bariatric surgery. They ...
MINNEAPOLIS — A reduced risk for death may balance out concerns about hyperkalemia when treating heart failure with renin-angiotensin system (RAS) inhibitors and mineralocorticoid receptor antagonists ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results